000 04065cam a2200325 a 4500
003 EG-GiCUC
008 180402s2017 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.15.M.Sc.2017.Sh.I
100 0 _aSherif Omar Abdalrafee Alsaid
245 1 0 _aImpact of rectal misoprostol on operative blood loss in previous one caesarean section women undergoing elective repeated lower segment caesarean section /
_cSherif Omar Abdalrafee Alsaid ; Supervised Soumaya Mohamed Hassan , Eman Aly Hussein , Ahmed Samir Rashwan
246 1 5 _aتأثير إستخدام دواء الميزوبروستول عن طريق المستقيم على فقدان الدم أثناء الولادة القيصرية التالية فى السيدات اللاتى سبق لهن إجراء ولادة قيصرية واحدة
260 _aCairo :
_bSherif Omar Abdalrafee Alsaid ,
_c2017
300 _a85 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics
520 _aObjective: The aim of study is to detect the effect of insertion of 400 micrograms rectal misoprostol given preoperatively 15 minutes prior to skin incision to reduce amount of intraoperative and early postoperative blood loss during elective repeated lower segment caesarean section. Study design:Double blinded randomized interventional prospective controlled study showing impact of preoperative rectal 400 microgram misoprostol on operative and postoperative blood loss in women with previous one caesarean section undergoing elective repeated lower segment caesarean section, The Study included 200 women undergoing elective cesarean delivery under spinal anesthesia, patients included in the study will be randomized into 2 groups: Group (A) (Study group): 100 women who will receive 400 micrograms rectal misoprostol preoperatively 15 minutes prior to skin incision and receiving the standard treatment in form of 20 IU oxytocin drip on 500 ml lactated Ringer's solution over half an hour immediately after delivery of the neonate. Group (B) (Control group): 100 women who will receive only the standard treatment in form of 20 IU oxytocin drip on 500 ml lactated Ringer's solution over half an hour immediately after delivery of the neonate. Results: There was statistically significant difference between both groups where the Studygroup showed lower levels than Control group in the mean intraoperative blood loss and mean postpartum blood loss (491 ±252 ml and 169.3 ± 81 ml versus 632.8 ±285.9 and 282.1 ±169.1 ml respectively, (P>0.001)), and there was statistically significant difference in percentage decrease in haemoglobin and haematocrit pre and postoperative in Control group more than Study group (14.38 ±3.67% and 36.27 ±6.2% versus 10.83 ±3.39% and 14.86 ±6.46% respectively, (P>0.001)), Also, there was statistically significant difference in percentage decrease in mean arterial pressure (MAP) pre and postoperative in Control group more than Study group (17.49 ±4.1% versus 11.44 ±3.91% respectively, (P>0.001)), and there was statistically significant difference in percentage increase in pulse pre and postoperative in Control group more than Study group (25.6 ±5.58% versus 11.98 ±4.93% respectively, (P>0.001)) Also, the need of additional uterotonics was significantly higher in Control group than Study group (21% versus 7% respectively, (P>0.001)), andpostoperative shivering and pyrexia was statistically higher in Study group than Control group (17% in study group versus 5% in control group,(P>0.001))
530 _aIssued also as CD
653 4 _aMisoprostol
653 4 _aOxytocin
653 4 _aPostpartum hemorrhage
700 0 _aAhmed Samir Rashwan ,
_eSupervisor
700 0 _aEman Aly Hussein ,
_eSupervisor
700 0 _aSoumaya Mohamed Hassan ,
_eSupervisor
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c65685
_d65685